Invention Publication
- Patent Title: ANTIBODIES TARGETING FLT3 AND USE THEREOF
-
Application No.: US17769257Application Date: 2020-10-14
-
Publication No.: US20240228628A9Publication Date: 2024-07-11
- Inventor: Hemanta Baruah , Gregory P. Chang , Ann F. Cheung , Asya Grinberg , Zong Sean Juo , Thomas J. McQuade
- Applicant: Dragonfly Therapeutics, Inc.
- Applicant Address: US MA Waltham
- Assignee: Dragonfly Therapeutics, Inc.
- Current Assignee: Dragonfly Therapeutics, Inc.
- Current Assignee Address: US MA Waltham
- International Application: PCT/US2020/055480 2020.10.14
- Date entered country: 2022-04-14
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/02
Abstract:
Disclosed are proteins with antibody heavy chain and light chain variable domains that can be paired to form an antigen-binding site targeting FLT3 on a cell, pharmaceutical compositions comprising such proteins, and therapeutic methods using such proteins and pharmaceutical compositions, including for the treatment of cancer.
Public/Granted literature
- US20240132598A1 ANTIBODIES TARGETING FLT3 AND USE THEREOF Public/Granted day:2024-04-25
Information query
